1. Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4′-demethyl epipodophyllotoxin thenylidene-β-D-glucoside and 4′-demethyl epipodophyllotoxin ethylidene-β-D-glucoside, in the L1210 leukemia cell;Allen;Cancer Res.,1978
2. Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives;Allen;Eur. J. Cancer,1975
3. 4′-Demethyl-epipodophyllic acid-9-(4,6-O-ethylidene-β-D-glucopyranoside), the major urinary metabolic of VP 16-213 in man;Allen,1976
4. Mechanism of cellular transport of two epipodophyllotoxin glucopyranoside derivatives, VM-26 (VM) and VP-16 (VP);Allen,1977
5. Podophylloloxin derivate VP 16-213;Arnold;Cancer Chemother. Pharmacol.,1979